News

In order to speed up research and development (R&D) for communicable diseases that disproportionately hurt lower-income nations, GSK plc announced a commitment of £1 billion over 10 years. This research will focus on novel and ground-breaking vaccines and medications to diagnose...

According to a story in the Welt Am Sonntag (WAS) newspaper, the launch of the vaccine developed by German pharmaceutical company BioNTech for the Omicron coronavirus type may be postponed because of a dispute with the regulator over the licencing...

We have come a long way when it comes to female contraception. From caps and diaphragms to implants and injections, the number of options presented to women are numerous and often complex.  However, with almost 45% of unmarried men...

The $39 billion acquisition of Alexion by AstraZeneca was accomplished less than a year ago. However, the main business is investing immediately in its subsidiary for rare diseases, particularly in Ireland. A couple of months after the acquisition was...

Do you wish to test for COVID-19 frequently in this new normal? If you do, you'll need to know where and how to obtain a COVID test. Luckily, more than two years after COVID-19 initially appeared, many tests are...

The clinical phase III trials of the COVID-19 nasal vaccination have been finished, according to the Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella, who stated the company will submit its data to the Drugs Controller General...

A team from Stanford University has developed the world's first amphibious all-terrain vehicle for medicine delivery. The millimeter-scale robot was created to negotiate complex biological environments by rolling, flipping, and spinning adverse effects through liquids. The fabrication of wirelessly controlled...